MindMotion Pro

FDA clears MindMaze's gamified home-neurorehabilitation platform
By Dave Muoio | 03:26 pm | June 12, 2018
Switzerland-based MindMaze announced today that it has received FDA clearance for the MindMotion Go, a gamified neurorehabilitation therapy platform for medium and light severity impairments able to be deployed in the patient’s home.